ICL Group Ltd. Files November 2024 6-K Report

TL;DR

ICL Group Ltd. filed its monthly 6-K report, standard procedure for foreign issuers.

AI Summary

ICL Group Ltd. filed a Form 6-K on November 12, 2024, reporting as a foreign private issuer. The filing is for the month of November 2024 and is incorporated by reference into their registration statement on Form S-8. The company, previously known as Israel Chemicals Ltd., is incorporated in Israel and has its principal executive offices in Tel Aviv.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding ICL Group Ltd.'s status as a foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would indicate a change in risk.

Key Players & Entities

• ICL Group Ltd. (company) — Registrant
• Israel Chemicals Ltd. (company) — Former company name
• Tel Aviv (location) — Principal executive office location

FAQ

Key Financial Figures

• $1.8 billion — eliver sequential growth, with sales of $1.8 billion and adjusted EBITDA of $383 million Ra
• $383 million — of $1.8 billion and adjusted EBITDA of $383 million Raising guidance for specialties-driven
• $1.75 billion — ember 30, 2024. Consolidated sales were $1.75 billion versus $1.86 billion in the prior year.
• $1.86 billion — lidated sales were $1.75 billion versus $1.86 billion in the prior year. Operating income was
• $214 m — in the prior year. Operating income was $214 million, with adjusted operating income o
• $243 m — lion, with adjusted operating income of $243 million, versus $227 million of operating
• $227 million — perating income of $243 million, versus $227 million of operating income in the third quarte
• $346 million — Adjusted EBITDA was $383 million versus $346 million. Diluted earnings per share were $0.09,
• $0 — illion. Diluted earnings per share were $0.09, with adjusted diluted EPS of $0.11,
• $0.11 — h adjusted diluted EPS of $0.11, versus $0.11 in the third quarter of last year. "IC
• $0.95 billion — ts specialties-driven EBITDA of between $0.95 billion to $1.05 billion, an increase from prev
• $1.05 b — iven EBITDA of between $0.95 billion to $1.05 billion, an increase from previous guidan
• $0.8 billion — , an increase from previous guidance of $0.8 billion to $1.0 billion. The company intends to
• $1.0 billion — om previous guidance of $0.8 billion to $1.0 billion. The company intends to limit its total
• $7.5 billion — its 2023 revenues totaled approximately $7.5 billion. For more information, visit the Compan

Filing Documents

• zk2432252.htm (6-K) — 1318KB
• image00001.jpg (GRAPHIC) — 2KB
• image00003.jpg (GRAPHIC) — 20KB
• image00004.jpg (GRAPHIC) — 1KB
• image00005.jpg (GRAPHIC) — 1KB
• 0001178913-24-003562.txt ( ) — 1353KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-13742 ICL GROUP LTD. (Exact name of registrant as specified in its charter) ICL Group Ltd. Millennium Tower 23 Aranha Street P.O. Box 20245 Tel Aviv, 61202 Israel (972-3) 684-4400 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F ICL GROUP LTD. INCORPORATION BY REFERENCE This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of ICL Group Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. In addition, this report on Form 6-K shall be deemed to be incorporated by reference into the Israeli Shelf Prospectus of ICL Group Ltd. filed with the Israel Securities Authority and dated February 28, 2022 (Filing Number: 2022-02-019821) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. ICL GROUP LTD. 1. Q3 2024 Results Financial Results and Business Overview September 30, 2024 ICL Group Ltd ICL Reports Third Quarter 2024 Results Continued to deliver sequential growth, with sales of $1.8 billion and adjusted EBITDA of $383 million Raising guidance for specialties-driven businesses Tel Aviv, Israel, November 11, 2024 – ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the third quarter ended September 30, 2024. Consolidated sales were $1.75 billion versus $1.86 billion in the prior year. Operating income was $214 million, with adjusted operating income of $243 million, versus $227 million of operating income in the third quarter of last year. Adjusted EBITDA was $383 million versus $346 million. Diluted earnings per share were $0.09, with adjusted diluted EPS of $0.11, versus $0.11 in the third quarter of last year. "ICL delivered another sequential increase in EBITDA, as well as versus the prior year, marking four consecutive quarters of improvement, despite lower potash prices. All three of our specialties-driven businesses showed significant year-over-year improvement in EBITDA, demonstrating the strength of our strategy and our ability to consistently deliver strong cash generation," said Raviv Zoller, president and CEO of ICL. "While we are still facing some challenges related to geopolitical uncertainties, we remain focused on developing our innovative product portfolio pipeline and executing targeted cost and efficiency efforts." The company raised its guidance for full year 2024 and now expects specialties-driven EBITDA of between $0.95 billion to $1.05 billion, an increase from previous guidance of $0.8 billion to $1.0 billion. The company intends to limit its total 2024 annual potash sales volumes to 4.6 million metric tons, already committed, which is in-line with 2023 sales volumes and in expectation of improved conditions in 2025. (1a) Financial Results and Business Overview This Financial Results and Business Overview is based on the Company's unaudited interim condensed consolidated financial statements as of and for the nine and three-month periods ended September 30, 2024 (hereinafter - Interim Financial Statements) , and is prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting", unless otherwise Financial Measures" section and the "Forward-looking Statements" section, respectively. About ICL ICL Group Ltd. is a leading global specialty minerals company which creates impactful solutions for humanity's sustainability challenges in the food, agriculture, and industrial markets. ICL leverages its unique bromine, potash, and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the Company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The Company employs more than 12,000 people worldwide, and its 2023 revenues totaled approximately $7.5 billion. For more information, visit the Company's website at www.icl-group.com [ 1 ] . [1] The reference to our website is intended to be an inactive textual reference and the information on, or accessible through, our website is not intended to be part of this Form 6-K. ICL Group Limited Q3 2024 Results 2 Financial Figures and

View Full Filing

View this 6-K filing on SEC EDGAR